Clinicomycological Profile of Invasive Fungal Infections in Intensive Care Unit (ICU) Patients in tertiary care hospital
International Journal of Pharmaceutical Quality Assurance · 09.07.2026 · 16 (10)
DOI: 10.25258/ijpqa.16.10.71 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 09.07.2026. Verfasst von Tanushree Narain und 3 weiteren Autor:innen.
Themen: Intensivpflege
Abstract (Originalsprache)
Background
Invasive fungal infections (IFIs) represent a significant cause of morbidity and mortality among patients admitted to intensive care units (ICUs). The increasing use of broad-spectrum antibiotics, invasive devices, prolonged hospitalization, and underlying immunosuppression has contributed to a rising incidence of IFIs. Early diagnosis based on laboratory evaluation is essential for timely management and improved clinical outcomes.
Aim
To assess the laboratory profile, fungal pathogen distribution, and clinical outcomes of invasive fungal infections in critically ill ICU patients. Methodology: A hospital-based observational study was conducted over a period of six months in the ICU of Patna Medical College and Hospital. Seventy patients aged 18 years and above with confirmed invasive fungal infections were included. Clinical specimens such as blood, sterile body fluids, and tissue samples were processed for fungal culture and species identification using standard mycological methods. Demographic details, clinical risk factors, and patient outcomes were recorded and analyzed using SPSS version 27.
Results
Most patients were male (60%), with the highest proportion belonging to the 41–60-year age group (41.4%). Prior antibiotic therapy (71.4%) and central venous catheterization (54.3%) were the most frequently observed risk factors. Candida species were the predominant pathogens, particularly Candida albicans (35.7%) and Candida tropicalis (17.1%), followed by Aspergillus species (22.9%). Recovery was observed in 71.4% of patients, while the mortality rate was 20%.
Conclusion
Candida species were the leading cause of IFIs in ICU patients. Early laboratory identification and clinicomycological profiling play a crucial role in improving patient outcomes.
Zitieren
APA
Narain, T., Ritu, K., Nandan, P., & Kumar, V. (2026). Clinicomycological Profile of Invasive Fungal Infections in Intensive Care Unit (ICU) Patients in tertiary care hospital. International Journal of Pharmaceutical Quality Assurance, 16(10). https://doi.org/10.25258/ijpqa.16.10.71
Vancouver
Narain T, Ritu K, Nandan P, Kumar V. Clinicomycological Profile of Invasive Fungal Infections in Intensive Care Unit (ICU) Patients in tertiary care hospital. International Journal of Pharmaceutical Quality Assurance. 2026;16(10). doi:10.25258/ijpqa.16.10.71
BibTeX
@article{Narain2026,
author = {Narain, Tanushree and Ritu, Kumari and Nandan, Pratulya and Kumar, Vijay},
title = {Clinicomycological Profile of Invasive Fungal Infections in Intensive Care Unit (ICU) Patients in tertiary care hospital},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {16},
number = {10},
doi = {10.25258/ijpqa.16.10.71}
}
EUVIMED